These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11991839)

  • 21. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunology insights into cardiac allograft rejection.
    Savasta M; Lentini S
    Rev Cardiovasc Med; 2011; 12(2):e68-76. PubMed ID: 21796085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys.
    Kawai T; Cosimi AB; Wee SL; Houser S; Andrews D; Sogawa H; Phelan J; Boskovic S; Nadazdin O; Abrahamian G; Colvin RB; Sach DH; Madsen JC
    Transplantation; 2002 Jun; 73(11):1757-64. PubMed ID: 12084998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term cardiac allograft survival across an MHC mismatch after "pruning" of alloreactive CD4 T cells.
    Hu M; Watson D; Zhang GY; Graf N; Wang YM; Sartor M; Howden B; Fletcher J; Alexander SI
    J Immunol; 2008 May; 180(10):6593-603. PubMed ID: 18453578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection.
    Metzler B; Gfeller P; Bigaud M; Li J; Wieczorek G; Heusser C; Lake P; Katopodis A
    J Immunol; 2004 Dec; 173(11):7025-36. PubMed ID: 15557200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Aminolevulinic acid with ferrous iron induces permanent cardiac allograft acceptance in mice via induction of regulatory cells.
    Hou J; Zhang Q; Fujino M; Cai S; Ito H; Takahashi K; Abe F; Nakajima M; Tanaka T; Xu J; Zou H; Ding Q; Li XK
    J Heart Lung Transplant; 2015 Feb; 34(2):254-63. PubMed ID: 25455753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells.
    Casiraghi F; Azzollini N; Cassis P; Imberti B; Morigi M; Cugini D; Cavinato RA; Todeschini M; Solini S; Sonzogni A; Perico N; Remuzzi G; Noris M
    J Immunol; 2008 Sep; 181(6):3933-46. PubMed ID: 18768848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Memory T-cell exhaustion and tolerance in transplantation.
    Hartigan CR; Sun H; Ford ML
    Immunol Rev; 2019 Nov; 292(1):225-242. PubMed ID: 31808170
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Chen JC; Ou LS; Chan CC; Kuo ML; Tseng LY; Chang HL
    Front Immunol; 2018; 9():418. PubMed ID: 29552016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection.
    Guillot C; Guillonneau C; Mathieu P; Gerdes CA; Ménoret S; Braudeau C; Tesson L; Renaudin K; Castro MG; Löwenstein PR; Anegon I
    J Immunol; 2002 Feb; 168(4):1600-9. PubMed ID: 11823487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marked prolongation of murine cardiac allograft survival using recipient immature dendritic cells loaded with donor-derived apoptotic cells.
    Xu DL; Liu Y; Tan JM; Li B; Zhong CP; Zhang XH; Wu CQ; Tang XD
    Scand J Immunol; 2004 Jun; 59(6):536-44. PubMed ID: 15182248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model.
    Shin YT; Adams DH; Wyner LR; Akalin E; Sayegh MH; Karnovsky MJ
    Transplantation; 1995 Jun; 59(12):1647-53. PubMed ID: 7604433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic cells,tolerance and therapy of organ allograft rejection.
    Raimondi G; Thomson AW
    Contrib Nephrol; 2005; 146():105-120. PubMed ID: 15567925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate Functions of Dendritic Cell Subsets in Cardiac Allograft Tolerance.
    Schroth S; Glinton K; Luo X; Thorp EB
    Front Immunol; 2020; 11():869. PubMed ID: 32431717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innate immunity in heart transplantation.
    Millington TM; Madsen JC
    Curr Opin Organ Transplant; 2009 Oct; 14(5):571-6. PubMed ID: 19542889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allochimeric molecules and mechanisms in abrogation of cardiac allograft rejection.
    Skelton TS; Tejpal N; Gong Y; Kubiak JZ; Kloc M; Ghobrial RM
    J Heart Lung Transplant; 2012 Jan; 31(1):73-84. PubMed ID: 21497519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of tolerance to heart transplants by simultaneous cotransplantation of donor kidneys may depend on a radiation-sensitive renal-cell population.
    Mezrich JD; Yamada K; Lee RS; Mawulawde K; Benjamin LC; Schwarze ML; Maloney ME; Amoah HC; Houser SL; Sachs DH; Madsen JC
    Transplantation; 2003 Aug; 76(4):625-31. PubMed ID: 12973099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
    van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
    Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An antagonist mutant IL-15/Fc promotes transplant tolerance.
    Zheng XX; Gao W; Donskoy E; Neuberg M; Ruediger M; Strom TB; Moll T
    Transplantation; 2006 Jan; 81(1):109-16. PubMed ID: 16421485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection.
    Ichikawa N; Demetris AJ; Starzl TE; Ye Q; Okuda T; Chun HJ; Liu K; Kim YM; Murase N
    Liver Transpl; 2000 Nov; 6(6):686-702. PubMed ID: 11084053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.